Penumbra (PEN) prices IPO above range

Penumbra (PEN) which designs and markets devices for the treatment of strokes and other vascular conditions, priced its initial public offering at $30 a share. 

The company sold 4 million shares, valuing it at about $1 billion. The IPO had been expected to price in a range between $25 a share to $28 a share. The Alameda, Calif., company plans to list on the New York Stock Exchange under the ticker symbol PEN.

• The company last year generated $2.2 million of net income on $125 million in revenue, and already has reported $81 million in revenue for the first half of 2015.

Address

1 Penumbra
ALAMEDA, CA 94502-7610
United States

Website 

http://www.penumbrainc.com

Key stats and ratios

	Q1 (Mar '17)	2016
Net profit margin	-4.24%	5.63%
Operating margin	-2.79%	-0.51%
EBITD margin	-	0.36%
Return on average assets	-3.43%	5.18%
Return on average equity	-3.89%	5.94%
Employees	1,500